ChanTest Overview

  • Founded
  • 1998

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 51

Employees
  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

  • Investments
  • 1

ChanTest General Information

Description

Provider of ion channel testing services. The company provides validated assays to test ion channels for pharmaceutical and biotech industries. It also provides functional screens for profiling drug candidates and ranking profiles during drug discovery processes.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Discovery Tools (Healthcare)
Drug Discovery
Primary Office
  • 14656 Neo Parkway
  • Garfield Heights, OH 44128
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ChanTest Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ChanTest‘s full profile, request access.

Request a free trial

ChanTest Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ChanTest Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ChanTest‘s full profile, request access.

Request a free trial

ChanTest Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000 26-Feb-2009 0000000000 Laboratory Services (Healthcare) 000000 00
To view ChanTest’s complete acquisitions history, request access »